ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - diphtheria toxoid; filamentous haemagglutinin (fha); haemophilus b; hepatitis b vaccines; pertactin; pertussis toxoid (pt); poliovirus type 1 inactivated; poliovirus type 2 inactivated; poliovirus type 3 inactivated; tetanus toxoid - אבקה ותרחיף להכנת תרחיף להזרקה - filamentous haemagglutinin (fha) 25 mcg/dose; diphtheria toxoid nlt 30 iu/dose; tetanus toxoid nlt 40 iu/dose; hepatitis b vaccines 10 mcg/dose; poliovirus type 1 inactivated 40 du/dose; poliovirus type 2 inactivated 8 du/dose; poliovirus type 3 inactivated 32 du/dose; haemophilus b 10 mcg/dose; pertactin 8 mcg/dose; pertussis toxoid (pt) 25 mcg/dose - bacterial and viral vaccines, combined - infantix hexa is indicated for primary and booster vaccination of infants against diphtheria, tetanus, pertussis, hepatitis b, poliomyelitis and disease caused by haemophilus influenza type b.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - diphtheria toxoid 30 iu / 0.5 ml; filamentous haemogglutinin (fha) 25 mcg / 0.5 ml - powder and suspension for suspension for injection - tetanus toxoid, combinations with diphtheria toxoid - active immunisation of all infants from the age of 2 months to 7 years of age against diptheria, tetanus, pertussis (dtp) and hib.

ישראל - עברית - Ministry of Health

sanofi israel ltd - conjugated to tetanus protein; diphtheria toxoid; filamentous haemagglutinin (fha); haemophilus influenzae type b polysaccharide; pertussis toxoid (pt); polio type i (mohoney); polio type ii ( m.e.f.1); polio type iii (saukett); tetanus toxoid - אבקה ותרחיף להכנת תרחיף להזרקה - polio type iii (saukett) 32 du / 0.5 ml; polio type ii ( m.e.f.1) 8 du / 0.5 ml; polio type i (mohoney) 40 du / 0.5 ml; filamentous haemagglutinin (fha) 25 mcg / 0.5 ml; pertussis toxoid (pt) 25 mcg / 0.5 ml; tetanus toxoid 40 iu / 0.5 ml; diphtheria toxoid 30 iu / 0.5 ml; haemophilus influenzae type b polysaccharide 10 mcg / 0.5 ml; conjugated to tetanus protein 18-30 mcg / 0.5 ml - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus

ישראל - עברית - Ministry of Health

medici ltd - diphtheria toxoid 2 iu / 0.5 ml; poliomyelitis virus type 1 40 du/dose - suspension for injection - diphtheria-poliomyelitis-tetanus - this combined vaccine is indicated for adults as a booster of a previous vaccination for the simultaneous prevention of diphtheria tetanus and poliomyelitis. refer to the official recommendations for vaccination schedules. this vaccine may be administered as a booster of a previous vaccination to children 6 or older in exceptional cases particularly in the case of a shortage of the diphtheria tetanus and poliovirus vaccine (dtpolio) recommended in the vaccination schedule.

ישראל - עברית - Ministry of Health

medici ltd - diphtheria toxoid 15 lf / 0.5 ml; filamentous haemogglutinin (fha) 5 mcg / 0.5 ml - suspension for injection - hemophilus influenzae b, combinations with pertussis and toxoids - primary vaccination of infants, at or above the age of two months and as a booster in children up to their 6th birthday against diphtheria, tetanus, pertussis and invasive haemophilus influenzae type b infection.

ישראל - עברית - Ministry of Health

medici ltd - diphtheria toxoid 15 lf / 0.5 ml; filamentous haemogglutinin (fha) 20 mcg / 0.5 ml - suspension for injection - hemophilus influenzae b, combinations with pertussis and toxoids - primary vaccination of infants, at or above the age of two months and as a booster in children up to their 6th birthday against diphtheria, tetanus, pertussis, poliomyelitis and invasive haemophilus influenzae type b infections.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - diphtheria toxoid 30 iu / 0.5 ml; filamentous haemogglutinin (fha) 25 mcg / 0.5 ml - suspension for injection - bacterial and viral vaccines, combined - this vaccine is indicated for booster vaccination against diphtheria, tetanus , pertussis, and poliomyelitis diseases in individuals from 16 months to 13 years of age inclusive.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - varicella zoster virus glycoprotein e antigen - אבקה ותרחיף להכנת תרחיף להזרקה - varicella zoster virus glycoprotein e antigen 50 mcg - zoster, purified antigen

ישראל - עברית - Ministry of Health

medici medical ltd, israel - diphtheria toxoid; filamentous haemagglutinin (fha); fimbrae tupes 2 + 3 (fim); pertactin (prn); pertussis toxoid vaccine; poliovirus type 1; poliovirus type 2; poliovirus type 3; prp of haemophilus infl. type b; tetanus toxoid - תרחיף להזרקה - pertactin (prn) 3 mcg ml; diphtheria toxoid 15 lf ml; tetanus toxoid 5 lf ml; pertussis toxoid vaccine 20 mcg ml; filamentous haemagglutinin (fha) 20 mcg ml; fimbrae tupes 2 + 3 (fim) 5 mcg ml; poliovirus type 1 40 du ml; poliovirus type 2 8 du ml; poliovirus type 3 32 du ml; prp of haemophilus infl. type b 10 mcg ml - bacterial and viral vaccines, combined - pediacel is indicated for immunization of children at or above the age of 2 months and as a booster in children up to their 7th birthday against diphtheria, tetanus, whooping cough, poliomyelitis and invasive haemophilus influenzae type b disease. in infants, three infectons are to be given intramuscularly at 2, 4 and 6 months of age followed by a booster at 18 months of age. children who have had pertusis, tetanus, diphtheria or haemophilus influenzae type b invasive disease should still be immunized since these clinical infections do not always confer immunity. children who have had natural pertussis can continue to receive pertussis - containing vaccines. human immunodeficiency virus (hiv) infected persons hiv- infected individuals, both asymptomatic and symptomatic, should be immunized with pediacel vaccine according to standard schedules.

ישראל - עברית - Ministry of Health

יגב ציוד רפואי ומעבדתי בע"מ - אחות - מכשיר לחימום / קירור החולה